Evaluation of the COVID-19 response in Spain: principles and requirements

García‐Basteiro, Alberto L.; Legido‐Quigley, Helena; Álvarez-Dardet, Carlos; Arenas, Àlex; Bengoa, Rafael; Borrell, Carme; Val, Margarita Del; Franco, Manuel; Gea‐Sánchez, Montserrat; Gestal, Juan; López-Valcarcel, Beatríz González; Hernández-Aguado, Ildefonso; March, Joan Carles; Martín-Moreno, José M.; Menéndez, Clara; Minué, Sergio; Muntañer, Carles; Porta, Miquel; Prieto-Alhambra, Daniel; Vives‐Cases, Carmen

doi:10.1016/s2468-2667(20)30208-5

Cited by 19 publications

(14 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…As in previous other studies and larger analyses [ 3 , 27 , 30 , 31 ], age remained the most important risk factor for unfavorable outcome. Furthermore, in line with several recent reports [ 29 , 32 ], we found that the poor graft function has a significant predictive value for KTx death following COVID-19.…”

Section: Discussionsupporting

confidence: 92%

“…This is in contrast with a smaller Belgian study, which found a similar mortality during the first 2 COVID waves [ 10 ]. During the first wave, Spain had disproportionately high prevalence, death toll, and mortality [ 29 ], whereas Romania and other East-European countries enforced a very strict lockdown and witnessed a limited outbreak. While refinements in patient management may have contributed to decreased mortality in the second wave, underdiagnosing mild cases during the first wave may have biased the analyses and results due to the identification of predominantly more severe cases seeking hospitalization.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Comparing the First and Second Wave of COVID-19 in Kidney Transplant Recipients: An East-European Perspective

Elec¹,

Bolboacă²,

Muntean³

et al. 2021

Eur Surg Res

View full text Add to dashboard Cite

Background: The present study examined whether patient characteristics, management, and outcome of kidney transplant recipients (KTx) with COVID-19 changed in the second versus the first pandemic wave. Methods: We reviewed all available data (demographics, medical history, comorbidities, therapeutic interventions, and outcome) on our KTx with COVID-19 during the first wave (March–September 2020, n = 33) and the second wave (October 2020–February 2021, n = 149) of the COVID-19 pandemic. Results: One hundred eighty-two out of our 1,503 KTx in active follow-up got COVID-19 during 12-month period, corresponding to a prevalence of 12.1%. No difference was found in age, gender distribution, comorbidities, body mass index, or baseline immunosuppression between the 2 COVID-19 waves. Bilateral COVID pneumonia was more frequent during the first wave. More KTx were managed as outpatients during the second wave (15 vs. 39%, p < 0.01). Calcineurin inhibitors were more sparingly reduced during the second wave, whereas antimetabolites were similarly reduced (91 vs. 86, p = ns). Admission to intensive care units was comparable between the first (27%) and second waves (23%). During the first wave, 8 out of 9 patients (89%) requiring intensive care died, whereas the mortality of the ICU patients in the second wave was 68% (23 deaths) (p = 0.2). The overall mortality was 24% during the first wave and 16% during the second wave (p = 0.21), while in-hospital mortality was identical between the COVID-19 waves (27%). Increasing age and poor allograft function were significant predictors of mortality. Conclusions: Most patient characteristics and outcome were comparable between the first 2 COVID-19 waves. More KTx were managed as outpatients without an overall negative impact on outcome.

show abstract

Section: Discussionsupporting

confidence: 92%

Section: Discussionmentioning

confidence: 99%

Comparing the First and Second Wave of COVID-19 in Kidney Transplant Recipients: An East-European Perspective

Elec¹,

Bolboacă²,

Muntean³

et al. 2021

Eur Surg Res

View full text Add to dashboard Cite

show abstract

“…Despite these limitations, this research presents both beneficial and critical features of Japan’s COVID-19 response in the early phase of the epidemic. As suggested in other countries, launching an independent panel for conducting an external evaluation will help improve a country’s COVID-19 response [ 17 , 128 , 129 ]; our research results support this conclusion and will be referenced in such circumstance.…”

Section: Discussionsupporting

confidence: 78%

Lessons Learned from Japan’s Response to the First Wave of COVID-19: A Content Analysis

Shimizu

Negita

2020

Healthcare

View full text Add to dashboard Cite

While the epidemiological impact of the coronavirus disease 2019 (COVID-19) pandemic has been relatively moderate in East-Asian countries, the pandemic has significantly impacted on citizens’ lives and livelihoods, and Japan is no exception. In the early phase of the COVID-19 pandemic, Japan managed unprecedented quarantines and realized the difficulty of controlling COVID-19, finally recording a relatively high number of deaths per million in the Western Pacific region. However, scant research has highlighted the distinctive features of Japan’s reaction and the challenges encountered. To clarify these points and examine Japan’s first response to COVID-19, we performed a content analysis. Minutes of expert meetings were analyzed from multiple viewpoints, including epidemiology, health systems, border control, and health communication. The obscure evolution of the testing strategy, the usefulness of retrospective contact tracing, the rapid scientific risk assessment, a sluggish expansion of health system capacity and response in border control, and misunderstanding between risk communication and crisis communication are made evident by our analysis. Examining previous responses and gathering lessons learned in each country will improve global responses to COVID-19 and strengthen regional health security. Therefore, while investing in public health and ensuring transparency, Japan needs to clarify the previous decision-making process of each countermeasure towards COVID-19.

show abstract

“…Siguiendo los requerimientos en la evaluación de la OMS, la valoración debe consistir en un examen imparcial, independiente e integral 16 .…”

Section: Principios De La Evaluación Y Posible Articulación Organizatunclassified

Reflexiones sobre cómo evaluar y mejorar la respuesta a la pandemia de COVID-19

Martín-Moreno¹,

Arenas²,

Bengoa³

et al. 2022

Gaceta Sanitaria

Self Cite

View full text Add to dashboard Cite

Evaluation of the COVID-19 response in Spain: principles and requirements

Cited by 19 publications

References 2 publications

Comparing the First and Second Wave of COVID-19 in Kidney Transplant Recipients: An East-European Perspective

Comparing the First and Second Wave of COVID-19 in Kidney Transplant Recipients: An East-European Perspective

Lessons Learned from Japan’s Response to the First Wave of COVID-19: A Content Analysis

Reflexiones sobre cómo evaluar y mejorar la respuesta a la pandemia de COVID-19

Contact Info

Product

Resources

About